Controlled Substance Precursors

The following substances are designated as immediate precursors used in the manufacture of controlled substances: A. phenyl acetone; B. ephedrine; C. phenyl-2-propanone; D. norephedrine; E. ethyl-1-methyl butyl diethyl malonate; F. allyl-1-methyl butyl diethyl malonate; G. hydroxyindole; H. 3,4,5-trimethoxybenzyl cyanide; I. 3,4,5-trimethoxybenzyl alcohol; J. 3,4,5-trimethoxyphenylacetonitraile; K. 3,4,5-trimethoxybenzoic acid amide; L. 4-benzyloxyindole; M. 4-chloro indole; N. indole; O. tryntophol; P. 3-indole glyoxylic acid; Q. 3-indole glyoxylic acid ethyl ester; R. lysergic acid; S. lysergic acid amide; 16.19.21 NMAC 6 T. ergotamine tartrate; U. 1-phenyl cyclohexylamine; V. 1-piperidinocyclohexanecarbonitrile; W. pseudoephedrine as a substance in a form not approved in 26-1-14 NMSA; X. methylamine; Y. methylformamide Z. phenylacetic acid; AA. anhydrous ammonia: (1) a person shall not possess any amount of anhydrous ammonia; (2) a person must store anhydrous ammonia in a container approved for the transport of anhydrous ammonia; (3) the provisions of this section do not apply to a: (a) person who is actively operating land used for agricultural purposes; (b) retail distributor; (c) wholesaler; (d) manufacturer; (e) warehouseman; (f) common carrier; or (g) person engaged in the regular course of conducting a lawful business; BB. red phosphorous; CC. iodine matrix, a retail distributor registrant, pharmacy, hospital, clinic may not sell more than 2 ounces of iodine matrix in a single transaction; DD. crystal iodine, a retail distributor registrant, pharmacy, hospital, clinic may not sell more than 2 ounces of iodine crystals in a single transaction. [03-07-80…08-27-90; 16.19.21.35 NMAC - Rn, 16 NMAC 19.21.35, 03-30-02; A, 12-01-03; A, 01-15-2005; A, 01-31-07